SHINVA(SH:600587) Sou Hu Cai Jing·2025-08-04 11:17Core Insights - The stock price of Xinhua Medical closed at 16.89 yuan, up 1.69%, with a rolling PE ratio of 15.98, marking a new low in 144 days, and a total market capitalization of 10.247 billion yuan [1] - The average PE ratio in the medical device industry is 54.32, with a median of 38.11, placing Xinhua Medical at the 33rd position in the industry ranking [1] Company Overview - Xinhua Medical specializes in the manufacturing and sales of medical devices and pharmaceutical equipment, providing compatible medical services and medical commerce [2] - The company is a leading entity in various industry associations and has developed several high-tech products, including the world's first peracetic acid low-temperature sterilizer and the first high-energy medical linear accelerator in China [2] - Xinhua Medical is recognized as a national key high-tech enterprise and has established multiple provincial-level research and development platforms, contributing to over 100 key technology innovation projects annually [2] Financial Performance - In the first quarter of 2025, the company reported revenue of 2.308 billion yuan, a year-on-year decrease of 8.74%, and a net profit of 160 million yuan, down 23.97%, with a gross profit margin of 23.79% [3] - The company's PE ratio (TTM) is 15.98, while the industry average is 54.32, indicating a significant valuation disparity [3]